Billings Clinic
Especially For:

Clinical Trials

Title   Lung Cancer: E1505 Completely Resected Stage 1B-IIIA
Description   A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage 1B (>4cm) - IIIA NSCLC.
IRB Number   CTSU E1505
Category   Lung
Inclusion/Notes   Must be 6-12 weeks after surgery and have had a lobectomy or pneumonectomy w mediastinal lymph node sampling
Status   Active
Start Date   09/14/2007
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Medical Oncologist
Contact Name   Judy Miller RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.